
Rojelio Mejia MD
Assistant Professor, Medicine, Baylor Coll of Med
Join to View Full Profile
1709 Dryden Rd# 620Houston, TX 77030
Phone+1 713-798-9121
Dr. Mejia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- National Institutes of Health Clinical CenterFellowship, Infectious Disease, 2008 - 2012
- University of Virginia Medical CenterResidency, Internal Medicine, 2006 - 2008
- Michigan State University College of Human MedicineClass of 2006
Certifications & Licensure
- TX State Medical License 2012 - 2025
- VA State Medical License 2006 - 2012
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- Rapid, High Sensitivity Detection of Antibodies to Trypanosoma cruzi using a Recombinant Tc24 Antigen-based Magneto-Immunoassay: A Pilot Study.Kavya L Singampalli, Bin Zhan, Rojelio Mejia, Peter B Lillehoj
The Journal of Infectious Diseases. 2025-03-06 - A Honduran Prevalence Study on Soil-Transmitted Helminths Highlights Serological Antibodies to Tm-WAP49 as a Diagnostic Marker for Exposure to Human Trichuriasis.Neima Briggs, Leroy Versteeg, Rojelio Mejia, Jeroen Pollet, Maria Jose Villar
The American Journal of Tropical Medicine and Hygiene. 2025-02-11 - 1 citationsMolecular Testing of Environmental Samples as a Potential Source to Estimate Parasite Infection.Rojelio Mejia, Barton Slatko, Cristina Almazan, Ruben Cimino, Alejandro Krolewiecki
Tropical Medicine and Infectious Disease. 2024-09-26
Press Mentions
- Infrastructure Neglect and Poverty Lead to Parasites in the Mississippi DeltaJanuary 1st, 2025
- ‘People Should Be Aware’: Eggs of Tiny Infectious Worm Found in Parks in New York and EuropeJune 30th, 2022
- Billionaire Mark Cuban’s New Drug Company Is Producing Low-Cost Generic Drugs Cutting 90% of the MarkupJanuary 29th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: